UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35929 National Research Corporation (Exact name of Registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer inco ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 001-35929 National Research Corporation (Exact name of Registrant as specified in its charter) (State o ...

Financial Data and Key Metrics Changes - Revenue for Q3 2023 increased slightly compared to Q3 2022, ending the quarter with $144.3 million in Total Revenue Contract Value (TRCV) [22] - Operating income decreased by 10% for Q3 2023 compared to Q3 2022, primarily due to growth in certain costs exceeding revenue growth [22] - The effective tax rate in Q3 2023 was 22%, down from 23% in 2022, mainly due to lower state income taxes [4] Business Line Data and Key Metrics Changes - The Human Understanding Program saw an average contract value growth of 13% from existing clients, aligning with previous successful rollouts [15] - The sales force has increased by 19% since the beginning of the year to capitalize on growing demand, contributing to two consecutive quarters of double-digit sales growth compared to the prior year [15] Market Data and Key Metrics Changes - The company is expanding its product offerings to capture a larger total addressable market while gaining market share in the core patient experience market [3] Company Strategy and Development Direction - The company is focused on accelerating revenue growth and expanding margins, with a plan that has shown sequential improvement over the past two quarters [20] - Increased investments in marketing and cybersecurity services are aimed at expanding brand recognition and supporting sales development [4] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in seeing the results of their efforts reflected in revenue per associate and operating margin in future periods [21] - The company remains well-positioned to execute a range of capital allocation alternatives, including funding for innovation, shareholder dividends, and share repurchases [17] Other Important Information - The company incurred $661,000 in nonrecurring state tax incentive adjustments during the quarter [4] - As of September 30, 2023, the company had approximately $20 million in net debt and $25 million available on the line of credit after funding various expenditures [17] Q&A Session Summary - No specific questions or answers were documented in the provided content, as the call transitioned directly to closing remarks after the prepared comments [5][6][12]

Table of Contents FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 001-35929 National Research Corporation (Exact name of Registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Ident ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 001-35929 National Research Corporation (Exact name of Registrant as specified in its charter) Delaware 47- ...

Table of Contents Delaware 47-0634000 1245 Q Street, Lincoln, Nebraska 68508 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35929 National Research Corporation (Exact name of Registrant as sp ...

National Research Corporation (NASDAQ:NRC) Q4 2022 Earnings Conference Call February 15, 2023 11:00 AM ET Company Participants Kevin Karas - CFO Linda Stacy - VP, Finance Conference Call Participants George D'Angelo - Alpine Peaks Capital Operator Hello, and welcome to the National Research Corporation Fourth Quarter 2022 Earnings Call. My name is Elliot and I'll be coordinating your call today. [Operator Instructions]. I would now like to hand over to Kevin Karas. The floor is yours. Please go ahead. Kevin ...

National Research Corporation (NASDAQ:NRC) Q3 2022 Earnings Conference Call November 3, 2022 10:00 AM ET Company Participants Linda Stacy - VP, Finance Kevin Karas - Chief Financial Officer Conference Call Participants George D'Angelo - Alpine Peaks Capital Operator Hello, and welcome to the National Research Corporation???s Third Quarter 2022 Earnings Call. My name is Bailey and I'll be your moderator for today's today. [Operator Instructions] I would now like to pass the call over to Kevin Karas, Chief F ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 001-35929 National Research Corporation (Exact name of Registrant as specified in its charter) (State o ...

National Research Corporation (NASDAQ:NRC) Q2 2022 Earnings Conference Call August 3, 2022 11:00 AM ET Company Participants Michael Hays - Founder and Chief Executive Officer Kevin Karas - Chief Financial Officer Conference Call Participants John Lewis - Willis Investment Counsel George D'Angelo - Alpine Peaks Capital Operator Hello, everyone, and welcome to the National Research Corporation???s Second Quarter 2022 Earnings Call. My name is Charlie and I'll be coordinating the call today. You will have the ...